Tag: GMP harmonization

How Multinational Companies Manage Multi-Country GMP Inspections

June 23, 2025November 14, 2025 digi

How Multinational Companies Manage Multi-Country GMP Inspections Strategies Multinational Companies Use to Manage Multi-Country GMP Inspections As pharmaceutical companies expand across borders, they face the complex task of managing Good Manufacturing Practice (GMP) inspections from multiple regulatory authorities. Each regulator—whether it’s the FDA, EMA, MHRA, CDSCO, or TGA—has its unique inspection requirements, formats, and expectations….

Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA), International GMP Inspection Standards and Harmonization

Key Differences Between US, EU, and WHO Inspection Approaches

May 20, 2025 digi

Key Differences Between US, EU, and WHO Inspection Approaches Comparing GMP Inspection Approaches: USFDA, EMA, and WHO In today’s global pharmaceutical landscape, manufacturing facilities are routinely audited by multiple regulatory bodies. While harmonization efforts continue to align standards, significant differences persist in the way key agencies—namely the USFDA, EMA, and WHO—conduct GMP inspections. Understanding these…

Global GMP Inspection Frameworks, International GMP Inspection Standards and Harmonization

Introduction to Global GMP Inspection Models and Harmonization Initiatives

May 19, 2025 digi

Introduction to Global GMP Inspection Models and Harmonization Initiatives Understanding International GMP Inspection Models and Global Harmonization Efforts Global pharmaceutical manufacturing is governed by diverse regulatory requirements. Each jurisdiction mandates GMP compliance to ensure drug safety, quality, and efficacy. However, these regulations often differ in execution, terminology, and inspection protocols, making cross-border compliance a significant…

Global GMP Inspection Frameworks, International GMP Inspection Standards and Harmonization